NYSE to delist Accretive Health?

Trading suspended and delisting proceedings have commenced.

The New York Stock Exchange has announced that the staff of NYSE Regulation has determined to commence proceedings to delist the Common Stock of Accretive Health, Inc. (NYSE:AH). Trading in the Company’s Common Stock will be suspended prior to the opening of trading on the NYSE on Monday, March 17, 2014.

The decision was reached because the company is a late filer and has not filed with the Securities and Exchange Commission its December 31, 2012 Form 10-K (the “2012 Form 10-K”) and certain of its fiscal 2013 Form 10-Q filings. On March 12, 2014, the Company announced that it anticipates it will not be able to complete the filing of its 2012 Form 10-K by March 19, 2014, the maximum allowable trading period under Section 802.01E of the NYSE’s Listed Company Manual.

NYSE Regulation notes that it may make an appraisal of, and determine on an individual basis, the suitability for continued listing of a listed security in light of all pertinent facts and circumstances whenever it deems such action appropriate. In addition, NYSE Regulation may, at any time, suspend trading in a security and commence delisting proceedings if it believes that continued dealings in or listing of the security on the NYSE are not advisable.

The company has a right to a review of this determination by a Committee of the Board of Directors of NYSE Regulation. The NYSE will apply to the SEC to delist the Common Stock upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

WHAT IS ADVFN?

ADVFN covers all things stock market.

From the news and opinion pieces on pages like this to share discussion forums, charting tools, financials, live share prices and Level 2, order book data

If you trade or invest ADVFN has the tools you need to make the right decisions.

• 

  101 Ways to Pick Stock Market Winners

  You need the number one bestselling investment guide, the definitive text for day traders, investors and stock pickers.

• 

  The Death of Wealth

  Dissecting the global economy and the financial markets, the book lays out the evidence for the next economic game changer: the Death of Wealth.

• 

  James Cummings

• 

  Jagdip Cheema

• 

  Zak Mir

• 

  Guardian Stockbrokers